Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > ESPL1(Gene name) > Human
  • Add your favorite
  • ESPL1 (Gene name),
  • Separin (Protein name ),  ESPL1_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    ESPL1(ESP1;KIAA0165);
    Protein name:
    Separin;
    Alternative:
    Extra spindle poles-like 1 protein;Caspase-like protein ESPL1;Separase;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with PTTG1. Interacts with RAD21.
    Function:
    Caspase-like protease, which plays a central role in the chromosome segregation by cleaving the SCC1/RAD21 subunit of the cohesin complex at the onset of anaphase. During most of the cell cycle, it is inactivated by different mechanisms.
    Subcellular Location:
    Cytoplasm Nucleus
    Protein Attributes:
    Sequence length:
    2120
    Sequence:
    50:
    MRSFKRVNFG | TLLSSQKEAE | ELLPALKEFL | SNPPAGFPSS | RSDAERRQAC | 
    100:
    DAILRACNQQ | LTAKLACPRH | LGSLLELAEL | ACDGYLVSTP | QRPPLYLERI | 
    150:
    LFVLLRNAAA | QGSPEATLRL | AQPLHACLVQ | CSREAAPQDY | EAVARGSFSL | 
    200:
    LWKGAEALLE | RRAAFAARLK | ALSFLVLLED | ESTPCEVPHF | ASPTACRAVA | 
    250:
    AHQLFDASGH | GLNEADADFL | DDLLSRHVIR | ALVGERGSSS | GLLSPQRALC | 
    300:
    LLELTLEHCR | RFCWSRHHDK | AISAVEKAHS | YLRNTNLAPS | LQLCQLGVKL | 
    350:
    LQVGEEGPQA | VAKLLIKASA | VLSKSMEAPS | PPLRALYESC | QFFLSGLERG | 
    400:
    TKRRYRLDAI | LSLFAFLGGY | CSLLQQLRDD | GVYGGSSKQQ | QSFLQMYFQG | 
    450:
    LHLYTVVVYD | FAQGCQIVDL | ADLTQLVDSC | KSTVVWMLEA | LEGLSGQELT | 
    500:
    DHMGMTASYT | SNLAYSFYSH | KLYAEACAIS | EPLCQHLGLV | KPGTYPEVPP | 
    550:
    EKLHRCFRLQ | VESLKKLGKQ | AQGCKMVILW | LAALQPCSPE | HMAEPVTFWV | 
    600:
    RVKMDAARAG | DKELQLKTLR | DSLSGWDPET | LALLLREELQ | AYKAVRADTG | 
    650:
    QERFNIICDL | LELSPEETPA | GAWARATHLV | ELAQVLCYHD | FTQQTNCSAL | 
    700:
    DAIREALQLL | DSVRPEAQAR | DQLLDDKAQA | LLWLYICTLE | AKMQEGIERD | 
    750:
    RRAQAPGNLE | EFEVNDLNYE | DKLQEDRFLY | SNIAFNLAAD | AAQSKCLDQA | 
    800:
    LALWKELLTK | GQAPAVRCLQ | QTAASLQILA | ALYQLVAKPM | QALEVLLLLR | 
    850:
    IVSERLKDHS | KAAGSSCHIT | QLLLTLGCPS | YAQLHLEEAA | SSLKHLDQTT | 
    900:
    DTYLLLSLTC | DLLRSQLYWT | HQKVTKGVSL | LLSVLRDPAL | QKSSKAWYLL | 
    950:
    RVQVLQLVAA | YLSLPSNNLS | HSLWEQLCAQ | GWQTPEIALI | DSHKLLRSII | 
    1000:
    LLLMGSDILS | TQKAAVETSF | LDYGENLVQK | WQVLSEVLSC | SEKLVCHLGR | 
    1050:
    LGSVSEAKAF | CLEALKLTTK | LQIPRQCALF | LVLKGELELA | RNDIDLCQSD | 
    1100:
    LQQVLFLLES | CTEFGGVTQH | LDSVKKVHLQ | KGKQQAQVPC | PPQLPEEELF | 
    1150:
    LRGPALELVA | TVAKEPGPIA | PSTNSSPVLK | TKPQPIPNFL | SHSPTCDCSL | 
    1200:
    CASPVLTAVC | LRWVLVTAGV | RLAMGHQAQG | LDLLQVVLKG | CPEAAERLTQ | 
    1250:
    ALQASLNHKT | PPSLVPSLLD | EILAQAYTLL | ALEGLNQPSN | ESLQKVLQSG | 
    1300:
    LKFVAARIPH | LEPWRASLLL | IWALTKLGGL | SCCTTQLFAS | SWGWQPPLIK | 
    1350:
    SVPGSEPSKT | QGQKRSGRGR | QKLASAPLRL | NNTSQKGLEG | RGLPCTPKPP | 
    1400:
    DRIRQAGPHV | PFTVFEEVCP | TESKPEVPQA | PRVQQRVQTR | LKVNFSDDSD | 
    1450:
    LEDPVSAEAW | LAEEPKRRGT | ASRGRGRARK | GLSLKTDAVV | APGSAPGNPG | 
    1500:
    LNGRSRRAKK | VASRHCEERR | PQRASDQARP | GPEIMRTIPE | EELTDNWRKM | 
    1550:
    SFEILRGSDG | EDSASGGKTP | APGPEAASGE | WELLRLDSSK | KKLPSPCPDK | 
    1600:
    ESDKDLGPRL | RLPSAPVATG | LSTLDSICDS | LSVAFRGISH | CPPSGLYAHL | 
    1650:
    CRFLALCLGH | RDPYATAFLV | TESVSITCRH | QLLTHLHRQL | SKAQKHRGSL | 
    1700:
    EIADQLQGLS | LQEMPGDVPL | ARIQRLFSFR | ALESGHFPQP | EKESFQERLA | 
    1750:
    LIPSGVTVCV | LALATLQPGT | VGNTLLLTRL | EKDSPPVSVQ | IPTGQNKLHL | 
    1800:
    RSVLNEFDAI | QKAQKENSSC | TDKREWWTGR | LALDHRMEVL | IASLEKSVLG | 
    1850:
    CWKGLLLPSS | EEPGPAQEAS | RLQELLQDCG | WKYPDRTLLK | IMLSGAGALT | 
    1900:
    PQDIQALAYG | LCPTQPERAQ | ELLNEAVGRL | QGLTVPSNSH | LVLVLDKDLQ | 
    1950:
    KLPWESMPSL | QALPVTRLPS | FRFLLSYSII | KEYGASPVLS | QGVDPRSTFY | 
    2000:
    VLNPHNNLSS | TEEQFRANFS | SEAGWRGVVG | EVPRPEQVQE | ALTKHDLYIY | 
    2050:
    AGHGAGARFL | DGQAVLRLSC | RAVALLFGCS | SAALAVRGNL | EGAGIVLKYI | 
    2100:
    MAGCPLFLGN | LWDVTDRDID | RYTEALLQGW | LGAGPGAPLL | YYVNQARQAP | 
    2120:
    RLKYLIGAAP | IAYGLPVSLR | 
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    MIM:
    UniGene:
    Pfam:
    String:
    KEGG:
    Uniprot:
     
    FOR
    ELISA Kit for Human Separin
    Cat.:
    E15160h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Separin
    Cat.:
    E15160m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Separin
    Cat.:
    U15160h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Separin
    Cat.:
    U15160m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Separin
    Cat.:
    P15160Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Separin
    Cat.:
    P15160Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Separin
    Monoclonal Antibody for Human Separin
    Protein for Human Separin
    Protein for Human Separin

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Regulation of human separase by securin binding and autocleavage."
      Waizenegger I. , Gimenez-Abian J.F. , Wernic D. , Peters J.-M.
      Curr. Biol.12:1368-1378(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);ENZYME REGULATION;AUTOCATALYTIC CLEAVAGE;MUTAGENESIS OF CYS-2029; 1483-GLU--ARG-1486; 1503-GLU--ARG-1506 AND 1532-GLU--ARG-1535
    2. 2.
      "Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1."
      Nagase T. , Seki N. , Ishikawa K. , Tanaka A. , Nomura N.
      DNA Res.3:17-24(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)
      tissue: Bone marrow.
    3. 3.
      "The finished DNA sequence of human chromosome 12."
      Scherer S.E. , Muzny D.M. , Buhay C.J. , Chen R. , Cree A. , Ding Y. , Dugan-Rocha S. , Gill R. , Gunaratne P. , Harris R.A. , Hawes A.C. , Hernandez J. , Hodgson A.V. , Hume J. , Jackson A. , Khan Z.M. , Kovar-Smith C. , Lewis L.R. , more...
      Nature440:346-351(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    4. 4.
      "Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis."
      Zou H. , McGarry T.J. , Bernal T. , Kirschner M.W.
      Science285:418-422(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PARTIAL NUCLEOTIDE SEQUENCE [MRNA];FUNCTION;INTERACTION WITH PTTG1
    5. 5.
      "Dual inhibition of sister chromatid separation at metaphase."
      Stemmann O. , Zou H. , Gerber S.A. , Gygi S.P. , Kirschner M.W.
      Cell107:715-726(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 1117-1130;ENZYME REGULATION;PHOSPHORYLATION AT SER-1126
    6. 6.
      "Anaphase specific auto-cleavage of separase."
      Zou H. , Stemman O. , Anderson J.S. , Mann M. , Kirschner M.W.
      FEBS Lett.528:246-250(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 1507-1517;ENZYME REGULATION;AUTOCATALYTIC CLEAVAGE;MUTAGENESIS OF ARG-1486; ARG-1506 AND ARG-1535
    7. 7.
      "Cohesin cleavage by separase required for anaphase and cytokinesis in human cells."
      Hauf S. , Waizenegger I.C. , Peters J.-M.
      Science293:1320-1323(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;INTERACTION WITH RAD21
    8. 8.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1396; SER-1399 AND SER-1508;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    9. 9.
      "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
      Gauci S. , Helbig A.O. , Slijper M. , Krijgsveld J. , Heck A.J. , Mohammed S.
      Anal. Chem.81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    10. 10.
      "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
      Mayya V. , Lundgren D.H. , Hwang S.-I. , Rezaul K. , Wu L. , Eng J.K. , Rodionov V. , Han D.K.
      Sci. Signal.2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1396 AND SER-1399;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Leukemic T-cell.
    11. 11.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1508;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    12. 12.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2026 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter